Skip to main content
. 2018 Oct 22;7(11):5803–5811. doi: 10.1002/cam4.1817

Table 1.

Socio‐demographic and clinical characteristics of respondents

Esophageal cancer patients Controls
(n = 2179)
Severe dysplasia/CIS
(n = 257)
Stage I
(n = 313)
Stage II
(n = 381)
Stage III
(n = 288)
Stage IV
(n = 204)
Total[Link]
(n = 1456)
Age (y, %)[Link]
≤55 14.0 14.7 12.9 16.0 13.7 14.1 52.0
56‐60 15.6 14.4 15.0 12.5 11.3 13.9 17.8
61‐65 33.9 30.0 24.1 26.0 27.9 28.1 17.0
≥66 36.5 40.9 48.0 45.5 47.1 43.9 13.2
Gender (%)[Link]
Male 67.7 73.5 76.4 76.7 74.0 73.8 49.8
Female 32.3 26.5 23.6 23.3 26.0 26.2 50.2
Marital status (%)
Married 96.1 94.9 95.8 96.2 94.1 95.5 94.5
Others 3.9 5.1 4.2 3.8 5.9 4.5 5.5
Occupation (%)[Link]
Farmer 88.3 82.4 79.0 77.4 77.5 81.0 N/A
Nonfarmer 11.7 17.6 21.0 22.6 22.5 19.0
Duration of illness (y, %)
1 46.7 41.2 36.2 43.4 36.3 40.7 N/A
2‐4 46.3 52.1 57.0 52.8 56.8 53.1
≥5 7.0 6.7 6.8 3.8 6.9 6.2
Other chronic diseases (%)
No 77.0 77.6 75.1 77.8 75.5 76.6 N/A
Yes 23.0 22.4 24.9 22.2 24.5 23.4
Therapeutic regimen (%)[Link]
Surgery 38.5 29.1 21.8 20.1 13.7 24.7 N/A
Radical resection 46.3 30.6 19.4 24.3 2.0 24.8
Radiotherapy 2.7 11.8 12.6 15.3 27.9 14.1
Chemotherapy 1.6 5.1 15.5 12.2 24.5 11.3
Surgery plus adjuvant chemotherapy 0.4 3.5 6.0 4.5 3.4 3.8
Concurrent chemoradiotherapy 0.4 6.4 10.0 13.9 9.8 8.2
Symptomatic treatment 4.3 10.9 13.4 6.6 16.2 10.2
Others 5.8 2.6 1.3 3.1 2.5 2.9
Study center (%)b,c
Cixian County 25.7 23.9 16.8 13.9 14.7 18.8 15.8
Wuwei City 24.5 23.0 24.4 11.1 5.4 18.6 13.9
Linzhou County 21.4 9.9 10.5 14.2 18.1 14.9 14.2
Harbin City 7.8 9.3 14.7 21.9 16.2 13.8 14.0
Changsha City 3.9 13.1 13.6 16.3 14.7 12.4 14.5
Sheyang County 7.8 11.2 12.3 12.8 15.2 11.7 13.8
Luoshan County 8.9 9.6 7.7 9.8 15.7 9.8 13.8

N/A, controls did not collect or did not have these characteristics.

Including 13 patients with a clinical stage classified as “unknown.”

Statistical difference between esophageal cancer patients and controls (P < 0.05).

Statistical difference among subgroups of esophageal cancer patients (P < 0.05).